J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 87 (2006), 2145-2148; DOI 10.1099/vir.0.82091-0

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riffault, S.
Right arrow Articles by Eléouët, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riffault, S.
Right arrow Articles by Eléouët, J.-F.
Agricola
Right arrow Articles by Riffault, S.
Right arrow Articles by Eléouët, J.-F.
© 2006 Society for General Microbiology

Short Communication

Replication of Bovine respiratory syncytial virus in murine cells depends on type I interferon-receptor functionality

Sabine Riffault1, Catherine Dubuquoy1, Nathalie Castagné1, Eric Baranowski2, Bernard Charley1 and Jean-François Eléouët1

1 Unité de Virologie et Immunologie Moléculaires, INRA, 78350 Jouy-en-Josas, France
2 UMR1225, École nationale vétérinaire de Toulouse (ENVT), 31076 Toulouse, France

Correspondence
Jean-François Eléouët
jean-francois.eleouet{at}jouy.inra.fr


   ABSTRACT
TOP
ABSTRACT
MAIN TEXT
REFERENCES
 
Bovine respiratory syncytial virus (BRSV) is able to counteract the alpha/beta interferon (IFN-{alpha}/beta)-mediated antiviral response for efficient replication in a host-specific manner. Mice models have been developed for experimental infection with human, but not bovine, respiratory syncytial virus strains. Here, it is shown that BRSV can replicate efficiently on primary cell cultures derived from type I IFN receptor-deficient, but not from wild-type IFN-competent, mice. However, BRSV infection was not enhanced in mice devoid of the type I IFN receptor. These results show that type I IFN is a major host-range determinant for infection at the cellular level, but that other factors control virus replication and pathology in vivo.

Published online ahead of print on 4 May 2006 as DOI 10.1099/vir.0.82091-0.


   MAIN TEXT
TOP
ABSTRACT
MAIN TEXT
REFERENCES
 
Human respiratory syncytial virus (HRSV) and Bovine respiratory syncytial virus (BRSV) are two closely related viruses that infect the respiratory tract of young children and calves, respectively (Larsen, 2000Down; Collins et al., 2001Down). HRSV and BRSV are the major cause of bronchiolitis and pneumonia in infants and calves, resulting in substantial economic losses. They belong to the genus Pneumovirus, family Paramyxoviridae, and are enveloped viruses with a single-, negative-strand RNA genome of about 15 kb that encodes 11 proteins.

Alpha/beta interferons (IFN-{alpha}/beta) represent the first line of host defence against viruses, as both IFN-{alpha} and IFN-beta trigger immediate innate antiviral activities (Conzelmann, 2005Down). All members of the IFN-{alpha}/beta family have a single common receptor, IFN-{alpha}/betaR, composed of two chains (IFNAR1 and IFNAR2). Binding of IFN-{alpha}/beta to its receptor results in a signalling cascade leading to the formation of a protein complex (STAT1, STAT2 and IRF9) named IFN-stimulated factor 3 (ISGF3) that translocates to the nucleus. ISGF3 binds to DNA sequences (IFN-stimulated response elements or ISRE) present in the promoters of hundreds of genes and promotes their transcription. The sensors triggering IFN production include members of the Toll-like receptor (TLR) family present at the cell surface or in endosomal compartments, namely TLR3, TLR4, TLR7, TLR8 and TLR9 (Jefferies & Fitzgerald, 2005Down). Signalling through TLRs leads to IRF3, IRF7 and NF-{kappa}B activation, factors controlling IFN-{alpha}/beta gene transcription (Moynagh, 2005Down).

Respiratory syncytial virus (RSV) has been reported to be a poor inducer of IFN-{alpha}/beta and partially resistant to its antiviral activity, indicating that this virus has evolved strategies to overcome the IFN system in order to establish a productive infection (Conzelmann, 2005Down). However, the capacity of HRSV to inhibit production of IFN-{alpha} in epithelial cells varies among virus strains (Schlender et al., 2005Down). Recombinant deletion mutants of RSV demonstrated that the two non-structural proteins NS1 and NS2 cooperatively suppress the induction of IFN-{alpha}/beta and the IFN-mediated antiviral response (Schlender et al., 2000Down; Bossert et al., 2003Down; Spann et al., 2004Down). It has been determined that NS1 and NS2 block activation of IRF3 in infected cells (Bossert et al., 2003Down) and that NS2 downregulates STAT2 expression (Ramaswamy et al., 2004Down, 2006Down; Lo et al., 2005Down). Furthermore, the host range of RSV infection depends upon the ability of NS1 and NS2 to neutralize the IFN-{alpha}/beta response of the host cell (Bossert & Conzelmann, 2002Down; Valarcher et al., 2003Down). NS proteins of BRSV might have evolved with the bovine host to optimally counteract bovine-cell antiviral responses.

HRSV replicates at low levels in the respiratory tract of rodents and these animals do not exhibit overt respiratory-tract disease, even if weight loss is observed when high titres of virus are used for inoculation. However the absence of a functional type I IFN pathway does not result in increased virus replication in vivo, indicating that IFN is not the sole host range-limiting factor (Johnson et al., 2005Down). Previous trials to infect mice with BRSV have been poorly reported, probably because of the inefficiency of this infection. However, recently, Almeida et al. (2004)Down have detected BRSV replication at low levels after experimental inoculation of wild-type BALB/c mice. We therefore wondered whether BRSV replication in mice could depend on its ability to escape from the host IFN response.

To address this issue, we took advantage of mice deficient in a functional type I IFN receptor (Müller et al., 1994Down). We derived primary cells from type 1 IFN receptor-competent (IFN-{alpha}/betaR+/+) or -deficient (IFN-{alpha}/betaR–/–) mice. IFN-{alpha}/betaR–/– and IFN-{alpha}/betaR+/+ cells were isolated from either lung or muscle tissue of 1-day-old pups and passaged once in Eagle's minimal essential medium (Gibco) containing 10 % gamma-irradiated fetal calf serum before BRSV infection. Primary cell cultures were plated on six-well plates and infected with BRSV at an m.o.i. of 10–2 for 2 h at 37 °C with the BRSV Maryland strain grown on bovine turbinate cells. We monitored the propagation of BRSV on IFN-{alpha}/betaR–/– or IFN-{alpha}/betaR+/+ cells by immunostaining with anti-F mAbs (Serotec) and a secondary fluorescein isothiocyanate-conjugated anti-mouse Ig (P.A.R.I.S.). Mock- or BRSV-infected cells were fixed with paraformaldehyde (4 %) at 0, 4, 8 and 12 days post-infection. As shown in Fig. 1Down(a), BRSV propagated on IFN-{alpha}/betaR–/– mouse-derived lung cells as efficiently as on bovine turbinate cells, but no virus was detected on IFN-{alpha}/betaR+/+ cells. At 8 days post-infection, about 50 % of the cell monolayer was infected, and all of the cells were infected at 12 days post-infection. The formation of syncytia was revealed by staining cell nuclei with the fluorescent dye Hoechst 33342 (Fig. 1aDown). Viral titres were determined to be 1.5±0.5x103 p.f.u. ml–1 at 8 days post-infection with IFN-{alpha}/betaR–/– cells, which are equivalent to viral titres obtained with bovine-cell infections (data not shown). Only traces of virus were detected in IFN-{alpha}/betaR+/+ cells infected with BRSV at 8 days post-infection or later. Similar results were obtained when using cells derived from muscles (data not shown) and when using two other BRSV strains, A2Gelfi and W2, that were isolated from calves (Valarcher et al., 2000Down) [results obtained with A2 strain are shown in Fig. 1(b)Down]. All of the virus strains used in this study were able to replicate on Madin–Darby bovine kidney (MDBK) cells (Fig. 1bDown), which are IFN-competent (Schlender et al., 2000Down; Bossert & Conzelmann, 2002Down).


Figure 1
View larger version (86K):
[in this window]
[in a new window]
 
Fig. 1. (a) Propagation of BRSV strain Maryland on bovine turbinate, IFN-{alpha}/betaR+/+- and IFN-{alpha}/betaR–/–-derived primary-cell cultures. BRSV replication was visualized by immunostaining with anti-F mAbs at 0, 4 and 8 days post-infection, as indicated (left panels), and cell nuclei were stained with Hoechst 33342 dye. (b) Infection of IFN-competent bovine MDBK cells, mouse IFN-{alpha}/betaR+/+- and IFN-{alpha}/betaR–/–-derived primary-cell cultures by the BRSV A2 and Maryland strains. The presence of virus was revealed as in (a). Original magnification x400.

 
As BRSV did not replicate on IFN-{alpha}/betaR+/+ cells, it is expected that BRSV NS proteins are unable to block either IFN-{alpha}/beta synthesis in murine cells or IFN-induced antiviral pathways. Cells derived from IFN-{alpha}/betaR–/– mice have lost the capacity to respond to IFN-induced stimuli, but might be still able to synthesize IFN-{alpha}/beta. We thus analysed the secretion of type I IFN in IFN-{alpha}/betaR–/– cells infected with BRSV. Type I IFN was monitored by a biological assay (Riffault et al., 1996Down). As shown in Table 1Down, IFN was detected in the supernatants of IFN-{alpha}/betaR–/– cells infected with BRSV at 8 and 12 days post-infection, but not in IFN-{alpha}/betaR+/+ infected cells. These results showed clearly that BRSV was unable to inhibit IFN synthesis in murine cells after infection. Besides, BRSV induced a higher level of IFN-{alpha}/beta in lung primary-cell cultures, where it also replicated more rapidly than in muscle primary-cell culture. These findings point towards a positive correlation between virus replication and IFN-{alpha}/beta induction.


View this table:
[in this window]
[in a new window]
 
Table 1. Induction of type I IFN by BRSV in IFN-{alpha}/betaR+/+- and IFN-{alpha}/betaR–/–-derived mouse cells

IFN-{alpha}/beta titres were monitored by a biological assay using the L929 murine cell line with vesicular stomatitis virus as challenge virus. An IFN-{alpha}/beta reference calibrated against an international standard was included in each assay to calculate sample IFN-{alpha}/beta titres (IU ml–1).

 
The data presented here show clearly that BRSV can replicate on IFN-incompetent murine primary cells as efficiently as on bovine cells, the virus escaping from the innate antiviral response. Furthermore, IFN was synthesized in IFN-{alpha}/betaR–/– cells infected with BRSV, showing that BRSV was unable to block IFN synthesis in these cells. The NS1 and NS2 proteins were shown to block the synthesis of IFN (Schlender et al., 2000Down; Spann et al., 2004Down). Our results suggest strongly that bovine NS1 and NS2 proteins are unable to interact with murine cellular factors involved in the IFN-activation pathway. The resulting establishment of antiviral mechanisms could explain, at least in part, the poor ability of BRSV to infect mice.

To investigate the factors limiting virus infection in mice, we first aimed to select an appropriate BRSV strain. For that purpose, we compared in BALB/c mice the Maryland BRSV strain with a field strain, 3761, isolated from infected calves and never passaged in cell culture (G. Meyer, personal communication). Mice were infected intranasally with 104 p.f.u. Maryland or 500 p.f.u. isolate 3761 at day 0 and sacrificed at various time points up to 23 days post-infection. Weight and clinical symptoms (ruffled fur) were recorded daily. Virus replication in lung was determined by using semi-quantitative RT-PCR to amplify the nucleoprotein gene [primer sequences as described by Boxus et al. (2005)Down] on RNA samples normalized for their beta-actin mRNA content. We did not observe symptoms of disease or weight loss, and recorded little (if any) inflammatory infiltrate in bronchoalveolar lavage (data not shown). However, semi-quantitative PCR showed some level of virus replication in lung, peaking at day 5 after infection and disappearing after 8 days. Interestingly, isolate 3761 replicated more strongly and for a longer period of time (up to day 12) than the Maryland strain (data not shown). We therefore decided to infect IFN-{alpha}/betaR+/+ and IFN-{alpha}/betaR–/– mice with the BRSV 3761 field isolate. We performed two independent experiments with four mice per genetic status and time point. Neither the level of virus replication nor the kinetics of replication was altered significantly by the absence of a functional IFN-signalling pathway (Fig. 2Down). Besides, both IFN-{alpha}/betaR+/+ and IFN-{alpha}/betaR–/– mice failed to show clinical symptoms (data not shown). By using the same mouse strains, similar findings were obtained previously with HRSV (Johnson et al., 2005Down). These and our data point to more complex mechanisms than type I IFN controlling virus replication and pathology in vivo.


Figure 2
View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2. Infection of IFN-{alpha}/betaR+/+ and IFN-{alpha}/betaR–/– mice with BRSV field isolate 3761. Mice were infected intranasally with 500 p.f.u. virus at day 0 and sacrificed at day 3, 6 or 10 post-infection. Virus replication in lung was determined by using semi-quantitative RT-PCR to amplify the nucleoprotein gene from RNA samples normalized for their beta-actin mRNA content. Individual mouse PCR results are shown (four mice per group and time point).

 


   ACKNOWLEDGEMENTS
 
We thank Gilles Meyer (ENVT) for providing the 3761 BRSV isolate, Guillaume Durand for his contribution to the PCR assays and René L'Haridon for his expertise on primary cell culture. This work was funded in part by the Département de Santé Animale of the INRA under the specific programme ‘Trans-zoonose’.


   REFERENCES
TOP
ABSTRACT
MAIN TEXT
REFERENCES
 
Almeida, R. S., Domingues, H. G., Coswig, L. T., D'Arce, R. C. F., de Carvalho, R. F. & Arns, C. W. (2004). Detection of bovine respiratory syncytial virus in experimentally infected balb/c mice. Vet Res 35, 189–197.[CrossRef][Medline]

Bossert, B. & Conzelmann, K.-K. (2002). Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J Virol 76, 4287–4293.[Abstract/Free Full Text]

Bossert, B., Marozin, S. & Conzelmann, K.-K. (2003). Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 77, 8661–8668.[Abstract/Free Full Text]

Boxus, M., Letellier, C. & Kerkhofs, P. (2005). Real time RT-PCR for the detection and quantitation of bovine respiratory syncytial virus. J Virol Methods 125, 125–130.[CrossRef][Medline]

Collins, P. L., Chanock, R. M. & Murphy, B. R. (2001). Respiratory syncytial virus. In Fields Virology, 4th edn, pp. 1443–1485. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.

Conzelmann, K.-K. (2005). Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J Virol 79, 5241–5248.[Free Full Text]

Jefferies, C. A. & Fitzgerald, K. A. (2005). Interferon gene regulation: not all roads lead to Tolls. Trends Mol Med 11, 403–411.[CrossRef][Medline]

Johnson, T. R., Mertz, S. E., Gitiban, N., Hammond, S., Legallo, R., Durbin, R. K. & Durbin, J. E. (2005). Role for innate IFNs in determining respiratory syncytial virus immunopathology. J Immunol 174, 7234–7241.[Abstract/Free Full Text]

Larsen, L. E. (2000). Bovine respiratory syncytial virus (BRSV): a review. Acta Vet Scand 41, 1–24.[Medline]

Lo, M. S., Brazas, R. M. & Holtzman, M. J. (2005). Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79, 9315–9319.[Abstract/Free Full Text]

Moynagh, P. N. (2005). TLR signalling and activation of IRFs: revisiting old friends from the NF-{kappa}B pathway. Trends Immunol 26, 469–476.[CrossRef][Medline]

Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. & Aguet, M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918–1921.[Abstract/Free Full Text]

Ramaswamy, M., Shi, L., Monick, M. M., Hunninghake, G. W. & Look, D. C. (2004). Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 30, 893–900.[Abstract/Free Full Text]

Ramaswamy, M., Shi, L., Varga, S. M., Barik, S., Behlke, M. A. & Look, D. C. (2006). Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344, 328–339.[CrossRef][Medline]

Riffault, S., Eloranta, M. L., Carrat, C., Sandberg, K., Charley, B. & Alm, G. (1996). Herpes simplex virus induces appearance of interferon-alpha/beta-producing cells and partially interferon-alpha/beta-dependent accumulation of leukocytes in murine regional lymph nodes. J Interferon Cytokine Res 16, 1007–1014.[Medline]

Schlender, J., Bossert, B., Buchholz, U. & Conzelmann, K.-K. (2000). Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J Virol 74, 8234–8242.[Abstract/Free Full Text]

Schlender, J., Hornung, V., Finke, S. & 7 other authors (2005). Inhibition of Toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 79, 5507–5515.[Abstract/Free Full Text]

Spann, K. M., Tran, K. C., Chi, B., Rabin, R. L. & Collins, P. L. (2004). Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78, 4363–4369.[Abstract/Free Full Text]

Valarcher, J.-F., Schelcher, F. & Bourhy, H. (2000). Evolution of bovine respiratory syncytial virus. J Virol 74, 10714–10728.[Abstract/Free Full Text]

Valarcher, J.-F., Furze, J., Wyld, S., Cook, R., Conzelmann, K.-K. & Taylor, G. (2003). Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77, 8426–8439.[Abstract/Free Full Text]

Received 31 March 2006; accepted 2 May 2006.



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riffault, S.
Right arrow Articles by Eléouët, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riffault, S.
Right arrow Articles by Eléouët, J.-F.
Agricola
Right arrow Articles by Riffault, S.
Right arrow Articles by Eléouët, J.-F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS